- Home
- SHLT vs RNTX Comparison
SHLT vs RNTX Comparison
Compare SHLT & RNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SHLT
- RNTX
- Stock Information
- Founded
- SHLT 1987
- RNTX 2001
- Country
- SHLT Israel
- RNTX United States
- Employees
- SHLT N/A
- RNTX N/A
- Industry
- SHLT Business Services
- RNTX Biotechnology: Pharmaceutical Preparations
- Sector
- SHLT Consumer Discretionary
- RNTX Health Care
- Exchange
- SHLT Nasdaq
- RNTX Nasdaq
- Market Cap
- SHLT 46.9M
- RNTX 43.3M
- IPO Year
- SHLT N/A
- RNTX N/A
- Fundamental
- Price
- SHLT $2.34
- RNTX $2.70
- Analyst Decision
- SHLT Strong Buy
- RNTX
- Analyst Count
- SHLT 1
- RNTX 0
- Target Price
- SHLT $11.00
- RNTX N/A
- AVG Volume (30 Days)
- SHLT 3.3K
- RNTX 101.2K
- Earning Date
- SHLT 09-26-2024
- RNTX 04-14-2025
- Dividend Yield
- SHLT N/A
- RNTX N/A
- EPS Growth
- SHLT N/A
- RNTX N/A
- EPS
- SHLT N/A
- RNTX N/A
- Revenue
- SHLT $55,939,000.00
- RNTX N/A
- Revenue This Year
- SHLT N/A
- RNTX N/A
- Revenue Next Year
- SHLT N/A
- RNTX N/A
- P/E Ratio
- SHLT N/A
- RNTX N/A
- Revenue Growth
- SHLT N/A
- RNTX N/A
- 52 Week Low
- SHLT $2.03
- RNTX $1.61
- 52 Week High
- SHLT $7.96
- RNTX $7.42
- Technical
- Relative Strength Index (RSI)
- SHLT 37.15
- RNTX N/A
- Support Level
- SHLT $2.24
- RNTX N/A
- Resistance Level
- SHLT $2.40
- RNTX N/A
- Average True Range (ATR)
- SHLT 0.14
- RNTX 0.00
- MACD
- SHLT -0.02
- RNTX 0.00
- Stochastic Oscillator
- SHLT 37.85
- RNTX 0.00
About SHLT SHL Telemedicine Ltd
SHL Telemedicine Ltd develops and markets personal telemedicine solutions. It consists of the transmission of medical data by an individual, from a remote location to a medical call center through telecommunication networks. The company offers solutions to subscribing patients, health insurance companies, hospitals, clinics, and physicians. It provides healthcare professional solutions to patients suffering from congestive heart failure, chronic obstructive pulmonary disease, and readmission solutions for reducing heart-related readmissions. In addition, consumer solutions include cardiac monitoring services. The company's geographical segments Israel, Europe, and the rest of the world, out of which majority revenue comes from Israel.